NovoCure Ltd Annual Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
NovoCure Ltd quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • NovoCure Ltd Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $8.99M, a 611% increase year-over-year.
  • NovoCure Ltd Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $35.3M, a 207% increase year-over-year.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2023 was $15.3M, a 43.2% increase from 2022.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2022 was $10.7M, a 70.3% increase from 2021.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2021 was $6.28M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15.3M +$4.62M +43.2% Jan 1, 2023 Dec 31, 2023 10-Q 2024-10-30
2022 $10.7M +$4.41M +70.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $6.28M +$7.98M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$1.71M -$112K -7.03% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$1.59M -$19.2M -109% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $17.6M +$4.45M +33.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $13.2M +$2.78M +26.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $10.4M +$5.95M +134% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $4.43M +$4.05M +1061% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $382K +$29K +8.22% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 $353K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.